McKesson Renews Wal-Mart Prime Vendor Deal, Loses Defense Department Bid
This article was originally published in The Pink Sheet Daily
Executive Summary
Wal-Mart has re-signed McKesson as its prime pharmaceutical vendor for two years
You may also be interested in...
McKesson Renews Distribution Deal With Wal-Mart
Wal-Mart says its new $4 generic prescription drug program did not impact negotiations.
Lupus Guidance Suggests Broad Use Of Health-Related Quality Of Life Endpoint
FDA’s draft guidance on systemic lupus erythematosus drug development lists four possible claims that the agency “may be willing to approve”: reduction in disease activity; organ-specific lupus treatment; complete clinical response/remission; and reduction in flares.